Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Mucolipidosis II is caused by mutations in GNPTA encoding the α/β GlcNAc-1-phosphotransferase

Abstract

Mucolipidosis II (ML II) is a fatal lysosomal storage disorder resulting from defects in the multimeric GlcNAc-1-phosphotransferase responsible for the initial step in the generation of the mannose 6-phosphate (M6P) recognition marker1. M6P residues on oligosaccharides of newly synthesized lysosomal enzymes are essential for efficient receptor-mediated transport to lysosomes2. We used the recombinant GlcNAc-1-phosphotransferase γ subunit as an affinity matrix to purify an unknown protein identified as the product of GNPTA (encoding GNPTA, previously known as MGC4170). The cDNA encodes a protein of 1,256 amino acids with two putative transmembrane domains and a complex preserved modular structure comprising at least six domains. The N-terminal domain of GNPTA, interrupted by a long insertion, shows similarities to bacterial capsule biosynthesis proteins. We identified seven mutations in GNPTA that lead to premature translational termination in six individuals with ML II. Retroviral transduction of fibroblasts from an individual with ML II resulted in the expression and localization of GNPTA in the Golgi apparatus, accompanied by the correction of hypersecretion of lysosomal enzymes. Our results provide evidence that GNPTA encodes a subunit of GlcNAc-1-phosphotransferase defective in individuals with ML II.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: Identification of the novel Golgi-membrane protein eluted from a GNPTG-affinity matrix.
Figure 2: Modular organization of GNPTA and bacterial capsule biosynthesis proteins.
Figure 3: Retroviral expression of GNPTA in ML II fibroblasts improves hypersecretion of lysosomal enzymes.

Accession codes

Accessions

BINDPlus

GenBank/EMBL/DDBJ

References

  1. Kornfeld, S. & Sly, W.S. I–Cell Disease and Pseudo-Hurler Polydystrophy: Disorders of Lysosomal Enzyme Phosphorylation and Localization. in The Metabolic and Molecular Bases of Inherited Disease (ed. Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D.) 3421–3452 (McGraw-Hill, New York, 2001).

    Google Scholar 

  2. Storch, S. & Braulke, T. Transport of lysosomal enzymes. in Lysosomes (ed. Saftig, P.) 17–26 (Eurekah, Landes Bioscience, Springer & Business Media, New York, 2005).

    Chapter  Google Scholar 

  3. Bao, M., Booth, J.L., Elemendorf, B.J. & Canfield, W.M. Bovine UDP-N-acetylglucosamine:lysosomal-enzyme N-acetylglucosamine-1-phosphotransferase. I. Purification and subunit structure. J. Biol. Chem. 271, 31437–31445 (1996).

    Article  CAS  Google Scholar 

  4. Paik, K.H. et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum. Mutat. 26, 308–314 (2005).

    Article  CAS  Google Scholar 

  5. Raas-Rothschild, A. et al. Molecular basis of variant pseudo-hurler polydystrophy (mucolipidosis IIIC). J. Clin. Invest. 105, 673–681 (2000).

    Article  CAS  Google Scholar 

  6. Tiede, S. et al. A novel mutation in UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) in two siblings with mucolipidosis type III alters a used glycosylation site. Hum. Mutat. 24, 535 (2004).

    Article  Google Scholar 

  7. Raas-Rothschild, A. et al. Genomic organisation of the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTAG) and its mutations in mucolipidosis III. J. Med. Genet. 41, e52 (2004).

    Article  CAS  Google Scholar 

  8. Eckert, V. et al. Cloning and functional expression of the human GlcNAc-1-P transferase, the enzyme for the committed step of the dolichol cycle, by heterologous complementation in Saccharomyces cerevisiae. Glycobiology 8, 77–85 (1998).

    Article  CAS  Google Scholar 

  9. Tzeng, Y.L., Noble, C. & Stephens, D.S. Genetic basis for biosynthesis of the (alpha 1 → 4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X. Infect. Immun. 71, 6712–6720 (2003).

    Article  CAS  Google Scholar 

  10. Pohlmann, R., Waheed, A., Hasilik, A. & von Figura, K. Synthesis of phosphorylated recognition marker in lysosomal enzymes is located in the cis part of Golgi apparatus. J. Biol. Chem. 257, 5323–5325 (1982).

    CAS  PubMed  Google Scholar 

  11. Hasilik, A. & Neufeld, E. Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. J. Biol. Chem. 255, 4937–4945 (1980).

    CAS  PubMed  Google Scholar 

  12. Riederer, M.A., Soldati, T., Shapiro, A.D., Lin, J. & Pfeffer, S.R. Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J. Cell Biol. 125, 573–582 (1994).

    Article  CAS  Google Scholar 

  13. Lübke, T. et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat. Genet. 28, 73–76 (2001).

    PubMed  Google Scholar 

  14. Storch, S., Pohl, S. & Braulke, T. A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting. J. Biol. Chem. 279, 53625–53634 (2004).

    Article  CAS  Google Scholar 

  15. Muschol, N. et al. Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages. Biochem. J. 368, 845–853 (2002).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by Deutsche Forschungsgemeinschaft (GRK464 to S.T. and SFB470/C6 to T.B.). We thank K. von Figura (University of Göttingen) and M. Cantz (University of Heidelberg) for the cultured fibroblasts from ML II patients (Z.B., M.A. and R.D., respectively).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Braulke.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Nucleotide sequence and deduced amino acid sequence of human MGC4170. (PDF 301 kb)

Supplementary Fig. 2

Domain organization of human MGC4170 and comparison with Drosophila melanogaster CG8027, Dictyostelium discoideum AAO52495, Entamoeba histolytica EAL52006, Mycobacterium tuberculosis CpsY, and Neisseria meningitides XcbA. (PDF 16 kb)

Supplementary Methods (PDF 21 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tiede, S., Storch, S., Lübke, T. et al. Mucolipidosis II is caused by mutations in GNPTA encoding the α/β GlcNAc-1-phosphotransferase. Nat Med 11, 1109–1112 (2005). https://doi.org/10.1038/nm1305

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1305

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing